Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Pelkmans, Leonie ^a,b   Kelchtermans, Hilde ^a,b   de Groot, Philip G ^c   Zuily, Stephane ^d,e   Regnault, Veronique ^e   Wahl, Denis ^d,e   Pengo, Vittorio ^f   de Laat, Bas ^a,b,c,g  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Synapse BV   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e UNIVERSITÉ DE LORRAINE   (France)

^f UNIVERSITY OF PADOVA   (Italy)

^g SANQUIN RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; EPITOPE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; REAGENT;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CHEMICAL REACTION; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PROTEIN CONFORMATION; PROTEIN DOMAIN;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84881528578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071402     Document Type: Article

References (21)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4: 295-306.
2. Reber G, Meijer P, (2012) In ECAT veritas? Lupus 21: 722-724.
3. de Laat B, Pengo V, Pabinger I, Musial J, Voskuyl AE, et al. (2009) The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 7: 1767-1773.
4. Iverson GM, Reddel S, Victoria EJ, Cockerill KA, Wang YX, et al. (2002) Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J Immunol 169: 7097-7103.
5. Ioannou Y, Pericleous C, Giles I, Latchman DS, Isenberg DA, et al. (2007) Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum 56: 280-290.
6. de Laat B, Derksen RH, Urbanus RT, de Groot PG, (2005) IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105: 1540-1545.
7. de Laat B, Derksen RH, van Lummel M, Pennings MT, de Groot PG, (2006) Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. Blood 107: 1916-1924.
8. Agar C, van Os GM, Morgelin M, Sprenger RR, Marquart JA, et al. (2010) Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood 116: 1336-1343.
9. Hammel M, Kriechbaum M, Gries A, Kostner GM, Laggner P, et al. (2002) Solution structure of human and bovine beta(2)-glycoprotein I revealed by small-angle X-ray scattering. J Mol Biol 321: 85-97.
10. Bouma B, de Groot PG, van den Elsen JM, Ravelli RB, Schouten A, et al. (1999) Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. Embo J 18: 5166-5174.
11. Schwarzenbacher R, Zeth K, Diederichs K, Gries A, Kostner GM, et al. (1999) Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. Embo J 18: 6228-6239.
12. Tincani A, Filippini M, Scarsi M, Galli M, Meroni PL, (2009) European attempts for the standardisation of the antiphospholipid antibodies. Lupus 18: 913-919.
13. Devreese K, (2012) Standardization of antiphospholipid antibody assays. Where do we stand? Lupus 21: 718-721.
14. Willis R, Harris EN, Pierangeli SS, (2012) Current international initiatives in antiphospholipid antibody testing. Semin Thromb Hemost 38: 360-374.
15. Dienava-Verdoold I, Boon-Spijker MG, de Groot PG, Brinkman HJ, Voorberg J, et al. (2011) Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity. J Thromb Haemost 9: 738-747.
16. Agar C, de Groot PG, Morgelin M, Monk SD, van Os G, et al. (2011) beta(2)-glycoprotein I: a novel component of innate immunity. Blood 117: 6939-6947.
17. Pierangeli SS, Favaloro EJ, Lakos G, Meroni PL, Tincani A, et al. (2012) Standards and reference materials for the anticardiolipin and anti-beta2glycoprotein I assays: a report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta 413: 358-360.
18. Iverson GM, Matsuura E, Victoria EJ, Cockerill KA, Linnik MD, (2002) The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA. J Autoimmun 18: 289-297.
19. Tsutsumi A, Ichikawa K, Matsuura E, Sawada KI, Koike T, (2000) Heterogeneous behavior of anti-beta2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with beta2-glycoprotein I. J Rheumatol. 27: 391-396.
20. Reber G, Schousboe I, Tincani A, Sanmarco M, Kveder T, et al. (2002) Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost 88: 66-73.
21. Urbanus RT, de Groot PG, (2011) Antiphospholipid antibodies-we are not quite there yet. Blood Rev 25: 97-106.